Literature DB >> 15134145

A spectroscopic study of the interaction of nigerloxin, a fungal metabolite, with serum albumin.

K C Sekhar Rao1, A G Appu Rao, A P Sattur.   

Abstract

Nigerloxin [2-amido-3-hydroxy-6-methoxy-5-methyl-4-(prop-1'-enyl) benzoic acid], a fungal metabolite, is an inhibitor of lipoxygenase and aldose reductase with free radical-scavenging properties. The interaction of nigerloxin with bovine serum albumin (BSA) was investigated using fluorescence spectroscopy and circular dichroic measurements. The fluorescence of BSA was quenched following interaction with nigerloxin, and this property was used to generate a binding constant. The estimated association constant was 1.01 +/- 0.2 x 10(6) M(-1). Job's method of continuous variation indicated that nigerloxin formed a 1:1 +/- 0.1 complex with BSA. To understand the nature of the interaction, the variance in the association constant as a function of temperature in the range of 14-45 degrees C was used to calculate the thermodynamic parameters. The thermodynamic parameters at 27 degrees C derived from the mass action plot and van't Hoff's plot were as follows: deltaG = -8.2 +/- 0.1 kcal/mol, deltaH approximately equal to 0 kcal/mol, and deltaS = 27.5 +/- 0.4 cal/mol/K (where deltaG is free energy, deltaH is enthalpy, and deltaS is entropy). Increasing ionic strength did not favor interaction. Circular dichroic measurements revealed that the interaction of nigerloxin with BSA did not lead to changes in the secondary structure of the protein. The reversibility of the interaction verified by the dilution method was found to be reversible. These measurements suggest that partial hydrophobic and partial ionic bonding play a role in the interaction of nigerloxin with BSA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134145     DOI: 10.1007/s11745-004-1216-4

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  16 in total

1.  Thyroxine binding. II. The nature of the binding site of human serum albumin.

Authors:  G L TRITSCH; N E TRITSCH
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

2.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

3.  The binding of thyroxine by serum albumin as measured by fluorescence quenching.

Authors:  R F Steiner; J Roth; J Robbins
Journal:  J Biol Chem       Date:  1966-02-10       Impact factor: 5.157

4.  The binding of N-acetylglucosamine to lysozyme. Studies on circular dichroism.

Authors:  K Ikeda; K Hamaguchi
Journal:  J Biochem       Date:  1969-10       Impact factor: 3.387

Review 5.  Serum albumin.

Authors:  T Peters
Journal:  Adv Protein Chem       Date:  1985

6.  Spectroscopic study of the interaction of gossypol with bovine serum albumin.

Authors:  B P Maliwal; A G Rao; M S Rao
Journal:  Int J Pept Protein Res       Date:  1985-04

7.  A comparative study of the interaction of chlorpromazine, trifluoperazine, and promethazine with mouse brain tubulin.

Authors:  A G Rao; J R Cann
Journal:  Mol Pharmacol       Date:  1981-03       Impact factor: 4.436

Review 8.  Fatty acid binding to plasma albumin.

Authors:  A A Spector
Journal:  J Lipid Res       Date:  1975-05       Impact factor: 5.922

9.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.

Authors:  S Curry; H Mandelkow; P Brick; N Franks
Journal:  Nat Struct Biol       Date:  1998-09

10.  Nigerloxin, a novel inhibitor of aldose reductase and lipoxygenase with Free radical scavenging activity from Aspergillus niger CFR-W-105.

Authors:  K C Sekhar Rao; S Divakar; K Naveen Babu; A G Appu Rao; N G Karanth; A P Sattur
Journal:  J Antibiot (Tokyo)       Date:  2002-09       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.